FDA Drug Recalls

Recalls / Active ingredient / Lansoprazole

Lansoprazole

11 FDA drug recalls involving the active ingredient “Lansoprazole.

DateClassProductFirm
2022-07-13Class IILansoprazole Delayed-Release Orally Disintegrating Tablets, 35 mg, 100-count blisters per carton, 10 Packs of Dr. Reddy's Laboratories, Inc.
2022-07-13Class IILansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100-count blisters per carton, 10 Packs of Dr. Reddy's Laboratories, Inc.
2022-04-15Class IILansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 10 Packs of 10 Tablets each, 100 Tablets peDr. Reddy's Laboratories, Inc.
2022-03-23Class IILansoprazole Delayed-Release Capsules, USP, 30 mg, 90-count bottle, Rx Only, Manufactured By: Dr. Reddy's LaboDr. Reddy's Laboratories, Inc.
2022-03-23Class IILansoprazole Delayed-Release Capsules, USP, 15 mg, a) 30-count bottle, (NDC 55111-398-30), b) 90-count bottle,Dr. Reddy's Laboratories, Inc.
2020-12-03Class IILansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) blister pack, Zydus Pharmaceuticals (USA) Inc
2020-12-03Class IILansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pacZydus Pharmaceuticals (USA) Inc
2020-10-27Class IILansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx onlyZydus Pharmaceuticals (USA) Inc
2020-10-27Class IILansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx onlyZydus Pharmaceuticals (USA) Inc
2019-03-11Class IIILansoprazole Delayed-Release Orally Disintegrating Tablets, 15 mg, 100 tablets (10 blister cards of 10 tabletsTeva Pharmaceuticals USA
2013-01-30Class IILansoprazole Delayed-release Capsules, USP, 30 mg, 500-count capsules per bottle, Rx only, Manufactured for: MMylan Pharmaceuticals Inc.